Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psoriasis
psoriasis
Is this the future of late-stage drug development? Lets hope so!
Forbes
Mon, 12/15/14 - 10:19 am
R&D
drug development
Stelara
JNJ
psoriasis
Novartis
Cosentyx
Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Motley Fool
Mon, 12/15/14 - 08:50 am
Novartis
Amgen
JNJ
Stelara
psoriasis
brodalumab
Cosentyx
Novartis' psoriasis drug tops J&J's Stelara as it speeds toward approval
Fierce Biotech
Fri, 12/12/14 - 08:51 am
Novartis
psoriasis
JNJ
Stelara
secukinumab
Sandoz loses bid to shield psoriasis drug
Yahoo/Reuters
Fri, 12/5/14 - 03:18 pm
Sandoz
psoriasis
Amgen
Enbrel
generics
Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown
Fierce Biotech
Wed, 11/26/14 - 11:38 am
Amgen
AstraZeneca
brodalumab
JNJ
Stelara
psoriasis
Novartis' Enbrel beater bounds toward psoriasis approval ahead of the crowd
Fierce Biotech
Fri, 11/21/14 - 10:30 am
Novartis
Enbrel
psoriasis
Cosentyx
Amgen psoriasis drug tops J&J's Stelara in Phase III study
Yahoo/Reuters
Wed, 11/12/14 - 08:32 am
Amgen
psoriasis
JNJ
brodalumab
Stelara
Benefits of Novartis psoriasis drug outweighs risk: FDA staff
Yahoo/Reuters
Thu, 10/16/14 - 09:19 am
Novartis
psoriasis
FDA
secukinumab
Novartis Says Psoriasis Drug Met End-Goal of Arthritis Studies
Bloomberg
Thu, 09/25/14 - 07:38 am
Novartis
psoriasis
secukinumab
psoriatic arthritis
Celgene Wins U.S. Approval of New Psoriasis Pill
Bloomberg
Tue, 09/23/14 - 04:58 pm
Celgene
psoriasis
FDA
Otezla
Merck licenses experimental psoriasis drug to India's Sun Pharma
Yahoo/Reuters
Wed, 09/17/14 - 04:35 pm
Merck
Sun Pharma
psoriasis
tildrakizumab
India
Big Pharma, Big Biotech prepare for showdown in next-gen psoriasis market
Fierce Pharma Marketing
Wed, 08/27/14 - 10:22 am
Embrel
Amgen
Pfizer
Eli Lilly
Novartis
Celgene
psoriasis
AstraZeneca
Lilly's Ixekizumab Superior to Etanercept and Placebo in Phase 3 Psoriasis Studies
Yahoo
Thu, 08/21/14 - 07:45 am
ixekizumab
etanercept
El Lilly
psoriasis
Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of Clinical Trial
Yahoo
Thu, 08/7/14 - 09:30 am
Cellceutix
psoriasis
Prurisol
clinical trials
Humira Still Key to AbbVie
Motley Fool
Sat, 07/26/14 - 10:10 am
AbbVie
Humira
psoriasis
Chron's Disease
rheumatoid arthritis
Novartis' Phase III Results on Secukinumab Published
Yahoo/Zacks.com
Thu, 07/10/14 - 11:30 am
psoriasis
secukinumab
Novartis
Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib 5 mg and 10 mg Twice Daily Compared to High-Dose ENBREL® in Adults with Moderate-to-Severe Chronic Plaque Psoriasis
Yahoo/BusinessWire
Sun, 03/23/14 - 09:48 am
Pfizer
tofacitinib
psoriasis
Experimental J&J psoriasis drug shows promise in study
Yahoo/Reuters
Sat, 03/22/14 - 12:10 pm
JNJ
psoriasis
guselkumab
AbbVie's Humira Still a Growth Engine
Motley Fool
Sun, 03/9/14 - 01:35 pm
AbbVie
Humira
rheumatoid arthritis
psoriasis
Idera: A Compelling Biotech Pick For March
Seeking Alpha
Fri, 03/7/14 - 12:12 pm
Idera Pharmaceuticals
psoriasis
autoimmune disease
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
next ›
last »